Research & Development for Improving Access to Medicines

As a leading global research and development-based pharmaceutical company, Eisai conducts drug discovery and research activities by applying cutting-edge knowledge and technologies. We consider that drug discovery for neglected tropical diseases (NTDs), malaria and tuberculosis are important R&D activities for improving access to medicines.

Eisai commits substantial resources, not only in-house R&D but also third-parties' contributions through “Open-Innovation” opportunities. Furthermore, Eisai also strives to contribute to research and development based pharmaceutical industry as a whole through the earliest publication of technical aspects of outcomes using the patent system.

Please visit to learn about Eisai’s Research Project Portfolio for neglected tropical diseases (NTDs) and three major infectious diseases (malaria, HIV/AIDS and tuberculosis).

In conducting clinical trials anywhere in the world, we must prioritize human rights, safety and welfare of the participating patients. Please visit to learn about ethical conduct and transparency of clinical trials around the world.